ROMEO (Rosuvastatin in Metabolic syndrOme)

Study identifier:D3560L00061

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 6-week, randomised, open-label, parallel group, multi-centre study to compare the efficacy of rosuvastatin 10mg with atorvastatin 10mg in the treatment of metabolic syndrome subjects with raised LDL-C

Medical condition

Metabolic Syndrome X

Phase

Phase 4

Healthy volunteers

No

Study drug

Rosuvastatin, Atorvastatin

Sex

All

Actual Enrollment

258

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Sept 2006
Primary Completion Date: 01 Jun 2008
Study Completion Date: 01 Jun 2008

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jun 2011 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria